COVID-19 detection Articles
-
Airborne SARS CoV-2 detection allows for adaptive mitigation of virus - Case Stduy
The University of Maryland, Baltimore County uses Smiths Detection’s Bioflash Biological Identifier to help confirm presence of virus in the air allowing for real time response to covid-19. Stop the Spread of Covid-19 At the start of the COVID-19 pandemic, Smiths Detection’s team based at its Biotechnology Center of Excellence in Baltimore, MD, began developing a new capability to ...
-
Smell tester for early detection of increasing Covid-19 infections
Functional principle The smell tester is measuring association velocity by using stable concentration profile of odor. Because of this the odor recognition is only dependent on the amount of available odor receptors. Changes in smell is a prominent symptom of COVID-19, as has consistently been demonstrated in many countries. By using the odor tester on patients, we could quickly detect COVID-19 ...
-
qPCR for SARS-CoV-2 Detection and Research: Introduction, Principles, and Applications
Introduction to Quantitative Polymerase Chain Reaction A highly delicate technique for the amplification and identification of deoxyribonucleic acid is polymerase chain reaction (PCR). In molecular biology, its conceptual simplification has made it the most utilized method and can, in theory, identify as little as a single segment of DNA. Therefore, for a huge variety of bacterial, fungal, viral, ...
By CD Genomics
-
Apple Watch Series 8 may not have a body temperature sensor after all
If you were hoping for more exciting updates with the Apple Watch Series 8, you might have to start tempering expectations. While it was initially thought that the next-generation watch would have a body temperature sensor, it’s looking like that may not be the case after all. A body temperature sensor for the Series 8 has been heavily rumored for some time now. ...
-
Nanostics is Developing and Validating a Simple Blood Test to Predict Severity of COVID-19 Disease in SARS-CoV-2 Positive Patients
Edmonton, Alberta - Nanostics Inc., a diagnostic healthcare company that focuses on developing tests to determine a patient's disease risk, announced today plans to develop and validate ClarityDX COVID-19; a simple blood test to predict the severity of COVID-19 disease in patients. Nanostics, in collaboration with the Canadian BioSample Repository (CBSR) at the University of Alberta and Century ...
-
Identify COVID-19 in the air with the BioFlash Biological Identifier
Airborne detection of COVID-19 can be used by medical centers, schools, and other locations to safely reopen. Click here to learn how BioFlash, our portable environmental monitoring solution, can help ensure indoor environments are free of infectious virus particles or detect the presence of airborne COVID-19 to stop the spread. Find out more about the BioFlash To see video, please ...
-
Production of trimeric SARS-CoV-2 spike protein by CHO cells for serological COVID-19 testing
Soon after the genetic sequence of SARS-CoV-2 was determined in January 2020, there was a rush to develop rapid diagnostics for the disease. The World Health Organization issued early guidance and protocols for the use of PCR to assist in diagnosing the disease. However, drawbacks like long turnaround times and invasive sampling for PCR tests led to a concerted push to develop rapid antibody ...
-
Evaluation of the Talis One Covid-19 Test System for the Rapid Detection of Sars-Cov-2 and Emerging Variants
Introduction The discovery of a novel coronavirus in December 2019 in the Wuhan province of China and subsequent global spread has caused a pandemic of the scale not seen since the 1918 H1N1 pandemic. The novel coronavirus, classified as the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is highly infectious and causes coronavirus disease 2019 (COVID-19), a respiratory and vascular ...
-
AXIM Biotech chooses the iPeak for the Dry Eye Disease Diagnostics
Founded in 2014 in California, AXIM® Biotechnologies, Inc. is a vertically integrated research and development company focused on improving the landscape for diagnosis of ophthalmological conditions such as Dry Eye Disease (DED) through rapid diagnostic tests. Additionally, it owns IP and has conducted research on SARS-CoV-2 (COVID-19) rapid neutralizing antibody tests to detect ...
By IUL S.A.
-
Israeli hospital pilots rapid diagnostics of blood cancer with Sight Diagnostics
Israeli-founded firm Sight Diagnostics, the company that uses AI and cutting-edge hardware to deliver rapid, complete blood count results, has signed a new research agreement with Jerusalem’s Shaare Zedek Medical Center to identify the possibility of blood cancer using a combination of images and data collected from Sight’s OLO device and patient clinical information provided by the ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you